Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21Cip1/WAF1/Sdi1

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1383-1393

  Staversky, Rhonda J ^a   Watkins, Richard H ^a   Wright, Terry W ^a   Hernady, Eric ^a   LoMonaco, Michael B ^a   D'Angio, Carl T ^a   Williams, Jacqueline P ^a   Maniscalco, William M ^a   O’Reilly, Michael A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; OXYGEN; PROTEIN P21;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; ENDOTHELIUM CELL; GENE EXPRESSION; HYPEROXIA; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FUNCTION; LUNG INJURY; MOUSE; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036792568     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64414-8     Document Type: Article

References (48)

1. Crapo JD, Barry BE, Foscue HA, Shelburne J: Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980, 122:123-143
2. Evans MJ, Hackney JD, Bils RF: Effects of a high concentration of oxygen on cell renewal in the pulmonary alveoli. Aerospace Med 1969, 40:1365-1368
3. Tryka AF, Witschi H, Gosslee DG, McArthur AH, Clapp NK: Patterns of cell proliferation during recovery from oxygen injury. Species differences. Am Rev Respir Dis 1986, 133:1055-1059
4. Evans MJ, Hackney JD: Cell proliferation in lungs of mice exposed to elevated concentrations of oxygen. Aerospace Med 1972, 43:620-622
5. Adamson IY, Bowden DH: The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest 1974, 30:35-42
6. Maniscalco WM, Watkins RH, Finkelstein JN, Campbell MH: Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am J Respir Cell Mol Biol 1995, 13:377-386
7. Adamson IY, Young L, Bowden DH: Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 1988, 130:377-383
8. O'Brodovich HM, Mellins RB: Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis 1985, 132:694-709
9. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM: Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 164:1971-1980
10. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 1996, 274:1664-1672
11. Chen X, Ko LJ, Jayaraman L, Prives C: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996, 10:2438-2451
12. Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace Jr AJ, O'Connor PM: Characterization of p21 Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 1996, 12:595-607
13. Luo Y, Hurwitz J, Massague J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21 Cip1. Nature 1995, 375:159-161
14. Li R, Waga S, Hannon GJ, Beach D, Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994, 371:534-537
15. Cacciuttolo MA, Trinh L, Lumpkin JA, Rao G: Hyperoxia induces DNA damage in mammalian cells. Free Radic Biol Med 1993, 14:267-276
16. Corroyer S, Maitre B, Cazals V, Clement A: Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes. J Biol Chem 1996, 271:25117-25125
17. Rancourt RC, Keng PC, Helt CE, O'Reilly MA: The role of p21 Cip1/WAF1 in growth of epithelial cells exposed to hyperoxia. Am J Physiol 2001, 280:L617-L626
18. Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA: p53-dependent induction of p21 Cip1/Waf1/Sdi1 protects against oxygen-induced toxicity. Toxicol Sci 2001, 63:214-222
19. Shenberger JS, Dixon PS: Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am J Respir Cell Mol Biol 1999, 21:395-402
20. McGrath SA: Induction of p21 WAF/CIP1 during hyperoxia. Am J Respir Cell Mol Biol 1998, 18:179-187
21. O'Reilly MA, Staversky RJ, Watkins RH, Maniscalco WM: Accumulation of p21(Cip1/WAF1) during hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 1998, 19:777-785
22. O'Reilly MA, Staversky RJ, Watkins RH, Reed CK, de Mesy Jensen KL, Finkelstein JN, Keng PC: The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress. Am J Respir Cell Mol Biol 2001, 24:703-710
23. O'Reilly MA, Staversky RJ, Stripp BR, Finkelstein JN: Exposure to hyperoxia induces p53 expression in mouse lung epithelium. Am J Respir Cell Mol Biol 1998, 18:43-50
24. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC: Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994, 264:713-716
25. O'Reilly MA, Staversky RJ, Huyck HL, Watkins RH, LoMonaco MB, D'Angio CT, Baggs RB, Maniscalco WM, Pryhuber GS: Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest 2000, 80:1845-1854
26. Elbadawi A: Hexachrome modification of Movat’s stain. Stain Technology 1976, 51:249-253
27. Russell Jr HK: A modification of Movat’s pentachrome stain. Arch Pathol 1972, 94:187-191
28. Woessner Jr JF: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961, 93:440-447
29. Konishi H, Steinbach G, Terry NH, Lee JJ, Dubin JA, Glober GA, Fujita K, Spaulding D, Cass L, Hittelman WN: Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium. Cancer Res 1996, 56:434-437
30. Alterman RB, Ganguly S, Schulze DH, Marzluff WF, Schildkraut CL, Skoultchi AI: Cell cycle regulation of mouse H3 histone mRNA metabolism. Mol Cell Biol 1984, 4:123-132
31. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF: Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 1998, 19:573-581
32. O'Reilly MA, Staversky RJ, Watkins RH, Maniscalco WM, Keng PC: p53-independent induction of GADD45 and GADD153 in mouse lungs exposed to hyperoxia. Am J Physiol 2000, 278:L552-L559
33. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA: Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998, 101:1970-1982
34. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816
35. el-Delry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
36. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211:90-98
37. Pan T, Mason RJ, Westcott JY, Shannon JM: Rat alveolar type II cells inhibit lung fibroblast proliferation in vitro. Am J Respir Cell Mol Biol 2001, 25:353-361
38. Bowden DH, Young L, Adamson IY: Fibroblast inhibition does not promote normal lung repair after hyperoxia. Exp Lung Res 1994, 20:251-262
39. Waldman T, Lengauer C, Kinzler KW, Vogelstein B: Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996, 381:713-716
40. Hoffmann JS, Johnson NP, Villani G: Conversion of monofunctional DNA adducts of cis-diamminedichloroplatinum (II) to bifunctional lesions. Effect on the in vitro replication of single-stranded DNA by Escherichia coli DNA polymerase I and eukaryotic DNA polymerases alpha. J Biol Chem 1989, 264:15130-15135
41. Auten Jr RL, Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH: Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am J Physiol 2001, 281:L336-L344
42. McDonald III ER, Wu GS, Waldman T, El-Deiry WS: Repair defect in p21 WAF1/CIP1 -/- human cancer cells. Cancer Res 1996, 56:2250-2255
43. Fan S, Chang JK, Smith ML, Duba D, Fornace Jr AJ, O'Connor PM: Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene 1997, 14:2127-2136
44. Sheikh MS, Chen YQ, Smith ML, Fornace Jr AJ: Role of p21 Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene 1997, 14:1875-1882
45. Fong GH, Rossant J, Gertsenstein M, Breitman ML: Role of the Fit-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70
46. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74
47. Mishra A, Doyle NA, Martin WJC: Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. Am J Respir Cell Mol Biol 2000, 22:543-549
48. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N: P21 Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996, 154:477-483